1,128
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Biosimilars: the paradox of sharing the same pharmacological action without full chemical identity

, , &
Pages 1343-1346 | Published online: 28 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alper Sevinç, Metin Özkan, Ahmet Özet, Faysal Dane, Berna Öksüzoğlu, Abdurrahman Işıkdoğan, Feyyaz Özdemir, Doğan Uncu, Mahmut Gümüş, Türkkan Evrensel, Arzu Yaren, Oğuz Kara & Salim Başol Tekin. (2018) Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia. OncoTargets and Therapy 11, pages 419-426.
Read now
Paul Declerck, Håkan Mellstedt & Silvio Danese. (2015) Biosimilars – terms of use. Current Medical Research and Opinion 31:12, pages 2325-2330.
Read now

Articles from other publishers (8)

Iqbal Ramzan. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters 1 16 .
Giovanna Stoppa, Carmen D’Amore, Anita Conforti, Giuseppe Traversa, Mauro Venegoni, Maurizio Taglialatela & Roberto Leone. (2018) Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study. BioDrugs 32:4, pages 367-375.
Crossref
Sang T. Jung & Dong‐Il Kim. 2018. Emerging Areas in Bioengineering. Emerging Areas in Bioengineering 679 695 .
Camila dos Reis, Ricardo Teixo, Fernando Mendes & Rui Santos Cruz. (2016) Biosimilar medicines – Review. International Journal of Risk & Safety in Medicine 28:1, pages 45-60.
Crossref
Carmen D’Amore, Roberto Da Cas, Mariangela Rossi & Giuseppe Traversa. (2016) Switching Between Epoetins: A Practice in Support of Biosimilar Use. BioDrugs 30:1, pages 27-32.
Crossref
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics 123 174 .
Martina Biggioggero, Marco Danova, Umberto Genovese, Francesco Locatelli, Pier Luigi Meroni, Fabrizio Pane & Francesco Scaglione. (2015) The challenging definition of naïve patient for biological drug use. Autoimmunity Reviews 14:6, pages 543-546.
Crossref
Young Sik Kim, Byung Wook Choi, Sung Wook Yang, Seon Mi Shin, Sang Wook Nam, Yun Sook Roh, Jae Young Lee, Kyung Jin Lee, Yong Jick Kim, Jun-Young Kwon & Dong-Il Kim. (2014) Biosimilars: Challenges and path forward. Biotechnology and Bioprocess Engineering 19:5, pages 755-765.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.